Compare IPCA Labs with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ALEMBIC PHARMA - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS ALEMBIC PHARMA IPCA LABS/
ALEMBIC PHARMA
 
P/E (TTM) x 32.0 22.1 144.4% View Chart
P/BV x 6.7 6.6 101.9% View Chart
Dividend Yield % 0.2 0.6 31.2%  

Financials

 IPCA LABS   ALEMBIC PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-19
ALEMBIC PHARMA
Mar-19
IPCA LABS/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs1,042664 156.9%   
Low Rs590412 143.1%   
Sales per share (Unadj.) Rs298.6208.7 143.1%  
Earnings per share (Unadj.) Rs35.031.0 112.9%  
Cash flow per share (Unadj.) Rs49.437.1 133.2%  
Dividends per share (Unadj.) Rs3.005.50 54.5%  
Dividend yield (eoy) %0.41.0 36.0%  
Book value per share (Unadj.) Rs247.1144.2 171.4%  
Shares outstanding (eoy) m126.35188.52 67.0%   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.72.6 106.0%   
Avg P/E ratio x23.317.4 134.3%  
P/CF ratio (eoy) x16.514.5 113.8%  
Price / Book Value ratio x3.33.7 88.5%  
Dividend payout %8.617.7 48.3%   
Avg Mkt Cap Rs m103,108101,461 101.6%   
No. of employees `00013.4NA-   
Total wages/salary Rs m7,8747,467 105.5%   
Avg. sales/employee Rs Th2,807.0NM-  
Avg. wages/employee Rs Th585.8NM-  
Avg. net profit/employee Rs Th329.0NM-  
INCOME DATA
Net Sales Rs m37,73239,347 95.9%  
Other income Rs m57794 614.9%   
Total revenues Rs m38,30939,441 97.1%   
Gross profit Rs m6,9018,736 79.0%  
Depreciation Rs m1,8241,152 158.3%   
Interest Rs m189184 102.5%   
Profit before tax Rs m5,4657,493 72.9%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-93 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0421,568 66.5%   
Profit after tax Rs m4,4225,844 75.7%  
Gross profit margin %18.322.2 82.4%  
Effective tax rate %19.120.9 91.2%   
Net profit margin %11.714.9 78.9%  
BALANCE SHEET DATA
Current assets Rs m23,77819,577 121.5%   
Current liabilities Rs m10,97514,896 73.7%   
Net working cap to sales %33.911.9 285.2%  
Current ratio x2.21.3 164.8%  
Inventory Days Days10490 115.6%  
Debtors Days Days6645 145.4%  
Net fixed assets Rs m20,36827,097 75.2%   
Share capital Rs m253377 67.0%   
"Free" reserves Rs m30,97126,811 115.5%   
Net worth Rs m31,22427,188 114.8%   
Long term debt Rs m1,4094,993 28.2%   
Total assets Rs m45,50747,778 95.2%  
Interest coverage x30.041.7 71.8%   
Debt to equity ratio x00.2 24.6%  
Sales to assets ratio x0.80.8 100.7%   
Return on assets %10.112.6 80.3%  
Return on equity %14.221.5 65.9%  
Return on capital %17.323.6 73.4%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Exports (fob) Rs m17,308NA-   
Imports (cif) Rs m6,266NA-   
Fx inflow Rs m17,30819,453 89.0%   
Fx outflow Rs m6,2666,065 103.3%   
Net fx Rs m11,04213,388 82.5%   
CASH FLOW
From Operations Rs m4,9238,120 60.6%  
From Investments Rs m-1,563-7,556 20.7%  
From Financial Activity Rs m-1,832590 -310.3%  
Net Cashflow Rs m1,5281,153 132.5%  

Share Holding

Indian Promoters % 45.9 74.1 61.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.4 2.9 393.1%  
FIIs % 25.3 9.1 278.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 13.9 125.2%  
Shareholders   36,892 49,328 74.8%  
Pledged promoter(s) holding % 2.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   SUVEN LIFESCIENCES  SUN PHARMA  PFIZER  TTK HEALTHCARE  SHASUN PHARMA  

Compare IPCA LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 661 Points; Banking and Finance Stocks Witness Huge Selling(Closing)

Indian share markets fell sharply today, led by weak Asian equities as worries of new lockdowns to stem surging coronavirus cases kept investors cautious worldwide.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

These 3 Recent Events Will Impact the Price of Gold(Fast Profits Daily)

Jul 1, 2020

Recent developments in the bullion market may put some short term pressure on gold prices.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Jul 14, 2020 03:35 PM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS - AJANTA PHARMA COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS